RxDoctor Payments Data
★ My doctorsLook up a doctor →

Miguel Cima, MD

Internal Medicine · Garden City, NYNPI 1053374868

Payments from drug & device makers

$13,135in general payments, 2019–2025

Across 579 payments — averaging $22.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$4K
  • Johnson & Johnson$2K
  • Mallinckrodt Hospital Products Inc.$2K
  • AbbVie$1K
  • Mallinckrodt Enterprises LLC$521
  • UCB, Inc.$446
  • plus $3K from 28 others

What the payments were for

  • Food & beverage$12,41795%
  • Education$7185%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Amgen(2 entities)172$4,341
Johnson & Johnson89$1,642
Mallinckrodt Hospital Products Inc.58$1,570
AbbVie(2 entities)42$1,222
Mallinckrodt Enterprises LLC16$521
UCB, Inc.30$446
Novartis19$386
AstraZeneca20$346
E.r. Squibb & Sons, L.L.C.23$326
ANI Pharmaceuticals, Inc.11$277
Mylan Specialty L.p.2$245
Bristol Myers Squibb15$209
GSK9$205
Genentech USA, Inc.10$184
Sobi, Inc7$155
Radius Health, Inc.7$130
Sentynl Therapeutics, Inc.9$129
Sunovion Pharmaceuticals Inc.1$111
Lilly USA, LLC5$109
Hikma Pharmaceuticals USA5$79
Medexus Pharma, Inc.5$70
Actelion Pharmaceuticals US, Inc.4$60
Regeneron Healthcare Solutions, Inc.3$58
Pacira Therapeutics, Inc.3$55
Janssen Scientific Affairs, LLC2$54
Kowa Pharmaceuticals America, Inc.2$36
Ultragenyx Pharmaceutical Inc.2$35
Collegium Pharmaceutical, Inc.2$32
Redhill Biopharma Inc.1$20
Pfizer1$19
Alfasigma USA, Inc.1$18
Bioventus LLC1$18
Arbor Pharmaceuticals, Inc.1$16
Boston Scientific1$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,135 in reported general payments places this provider in the 90th percentile of 9,771 internal medicine providers in New York.

See all internal medicine providers in New York →

Medicare billing

Part B allowed, 2024
$26,940
Medicare patients
45
Services billed
116

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl88$1,678
Leflunomide11$1,137
Ranolazine ErRanolazine13$1,036
Duloxetine Hcl40$974
Hydroxychloroquine Sulfate26$952
Mesalamine12$773
Levothyroxine Sodium26$639
Gabapentin36$634
Methenamine Hippurate11$603
Pregabalin32$456
Prednisone74$434
Dicyclomine Hcl27$428
Diazepam44$409
Pantoprazole Sodium13$369
Rosuvastatin Calcium14$341

Paid to pharmacies, not to this prescriber.

Other internal medicine in Garden City

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →